References
- Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017; 51: 47-55. 10.1515/raon-2017-000828265232
- Jolly S, Soni P, Gaffney DK, Biagioli M, Elshaikh MA, Jhingran A, et al. ACR Appropriateness Criteria(R) Adjuvant Therapy in Vulvar Cancer. Oncology 2015; 29: 867-75.
- Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 1990; 38: 309-14.10.1016/0090-8258(90)90064-R2227541
- Beriwal S, Coon D, Heron DE, Kelley JL, Edwards RP, Sukumvanich P, et al. Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. Gynecol Oncol 2008; 109: 291-5. 10.1016/j.ygyno.2007.10.02618455637
- Mahner S, Jueckstock J, Hilpert F, Neuser P, Harter P, de Gregorio N, et al. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst 2015; 107: 1-12. 10.1093/jnci/dju426
- Montana GS, Thomas GM, Moore DH, Saxer A, Mangan CE, Lentz SS, et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 2000; 48: 1007-13. 10.1016/S0360-3016(00)00762-811072157
- Gill BS, Bernard ME, Lin JF, Balasubramani GK, Rajagopalan MS, Sukumvanich P, et al. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NCDB) analysis. Gynecol Oncol 2015; 137: 365-72. 10.1016/j.ygyno.2015.03.05625868965
- Te Grootenhuis NC, van der Zee AG, van Doorn HC, van der Velden J, Vergote I, Zanagnolo V, et al. Sentinel nodes in vulvar cancer: long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol 2016; 140: 8-14. 10.1016/j.ygyno.2015.09.07726428940
- Oonk MH, van Hemel BM, Hollema H, de Hullu JA, Ansink AC, Vergote I, et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010; 11: 646-52. 10.1016/S1470-2045(10)70104-220537946
- Van Der Zee AGJ, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008; 26: 884-9. 10.1200/JC0.2007.14.056618281661
- de Hullu JA, van der Zee AG. Surgery and radiotherapy in vulvar cancer. Crit Rev Oncol Hematol 2006; 60: 38-58. 10.1016/j.critrevonc.2006.02.00816829120
- Vakselj A, Bebar S. The role of sentinel lymph node detection in vulvar carcinoma and the experiences at the Institute of Oncology Ljubljana. Radiol Oncol 2007; 41: 167-73. 10.2478/v10019-007-0027-4
- Benedet JL, Bender H, Jones H, Ngan H, Pecorelli S, Staging classifications and clinical practice guidelines of gynaecologic cancers. Int J Gynaecol Obstet 2000; 70: 207-312. 10.1016/S0020-7292(00)90001-8
- Levenback CF, Ali S, Coleman RL, Gold MA, Fowler JM, Judson PL, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a Gynecologic Oncology Group study. J Clin Oncol 2012; 30: 3786-91. 10.1200/JCO.2011.41.252822753905
- Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986; 68: 733-40.3785783
- Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 1991; 164: 997-1003.10.1016/0002-9378(91)90573-A2014852
- De Hullu JA, Hollema H, Lolkema S, Boezen M, Boonstra H, Burger MPM, et al. Vulvar carcinoma. The price of less radical surgery. Cancer 2002; 95: 2331-8. 10.1002/cncr.10969
- Ignatov T, Eggemann H, Burger E, Costa SD, Ignatov A. Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins. J Cancer Res Clin Oncol 2016; 142: 489-95. 10.1007/s00432-015-2060-926498775
- Fons G, Groenen SMA, Oonk MHM, Ansink AC, van der Zee AGJ, Burger MPM, et al. Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial. Gynecol Oncol 2009; 114: 343-5. 10.1016/j.ygyno.2009.05.01719481242
- Viswanathan AN, Pinto AP, Schultz D, Berkowitz R, Crum CP. Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol 2013; 130: 545-9. 10.1016/j.ygyno.2013.05.03623747330
- Parthasarathy A, Cheung MK, Osann K, Husain A, Teng NN, Berek JS, et al. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Gynecol Oncol 2006; 103: 1095-9. 10.1016/j.ygyno.2006.06.03016889821
- Woelber L, Eulenburg C, Choschzick M, Kruell A, Petersen C, Gieseking F, et al. Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment. Int J Gynecol Cancer 2012; 22: 503-8. 10.1097/IGC.0b013e31823eed4c22266935
- Farias-Eisner R, Cirisano FD, Grouse D, Leuchter RS, Karlan BY, Lagasse LD, et al. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for Stage I and II (T1-2 N0-1 M0) Disease. Gynecol Oncol 1994; 53: 55-8. 10.1006/gyno.1994.1087
- Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001; 358: 781-6. 10.1016/S0140-6736(01)05965-711564482
- Eifel P. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol 1995; 59: 51-6. 10.1006/gyno.1995.12677557615
- Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 1998; 42: 79-85.974782310.1016/S0360-3016(98)00193-X
- Geisler JP, Manahan KJ, Buller RE. Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration. Gynecol Oncol 2006; 100: 53-7. 10.1016/j.ygyno.2005.06.06816257042
- Gerszten K, Selvaraj RN, Kelley J, Faul C. Preoperative chemoradiation for locally advanced carcinoma of the vulva. Gynecol Oncol 2005; 99: 640-4. 10.1016/j.ygyno.2005.07.12616169579
- Koh WJ, ChiuM, Stelzer KJ, Greer BE, Mastras D, Comsia N, Russell KJ GT. Femoral vessel depth and the implications for groin node radiation. Int J Radiat Oncol Biol Phys 1993; 15: 969-74.
- Chapman B V, Gill BS, Viswanathan AN, Balasubramani GK, Sukumvanich P, Beriwal S. Adjuvant radiation therapy for margin-positive vulvar squamous cell carcinoma: defining the ideal dose-response using the national cancer data base. Int J Radiat Oncol Biol Phys 2016; 97: 1-11. 10.1016/j.ijrobp.2016.09.023
- Chan JK, Sugiyama V, Pham H, Gu M, Rutgers J, Osann K, et al. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol 2007; 104: 636-41. 10.1016/j.ygyno.2006.10.00417095080